INTRODUCTION
Classical Hodgkin lymphoma (cHL) microenvironment is modulated by cytokines and chemokines produced by HRS cells and is thought to contribute to tumour cell growth and escape from immunosurveillance (1) . We have shown recently that in EBV+ pediatric cHL the tumor microenvironment is characterized by a cytotoxic/Th1 profile (2) . Furthermore, cases with a small number FOXP3+ regulatory T-cells and a FOXP3/CD8 ratio <1 in the tumor microenvironment were associated with an improved outcome. We, therefore, hypothesized that in pediatric EBV+ cHL an effective cytotoxic immune response directed against viral or tumor antigens may be triggered in the tumor microenvironment (2-3).
Recent studies have consistently reported that high numbers of tumorassociated macrophages (TAM) are associated with adverse outcome in adult cHL (4) (5) (6) .
As yet, the specific role of TAM in pediatric cHL has not been studied.
Macrophages can be polarized toward a pro-inflammatory phenotype (M1 macrophages) with tumoricidal activity or toward a regulatory function (M2 macrophages) which are characterized by functions in tissue repair, remodeling and promotion of T helper 2 (Th2) immune response (7) (8) (9) . It is generally thought, that M2 macrophages are predominantly found in the microenvironment of malignant tumours. In agreement with this notion, macrophages expressing CD163 (considered to be a marker of M2 macrophages)
were associated with adverse outcome in a study of adult cHL (5) .
Dendritic cells (DCs) are critically important in the initiation and regulation of immune responses, driving Th1 or Th2 type responses, or promoting antigen-specific tolerance (10) (11) (12) . Additionally, plasmacytoid DC (pDC) are able to induce regulatory T (Treg) cells (13) (14) .
As immune reactions are shaped by cross-talk between innate and adaptive immune system (15) (16) , it is likely that the number, type and functional status of Based on the hypothesis that the lymphocytes from the tumor microenvironment modulate and in turn are modulated by macrophages and DCs, we have examined TAMs and DCs in pediatric cHL in the context of our previous analysis of lymphocyte subsets (2- 3) and we have investigated their impact on prognosis.
MATERIAL AND METHODS

Patients
One hundred HIV-negative children and adolescents (up to 18 year old) diagnosed with cHL at the Instituto Nacional do Câncer (INCA, Brazil) between 1999 and 2006 were included in this study. The clinical features of these cases have been previously described (2) . All patients were treated according to standard pediatric protocols as previously described (2) . For five cases there was not sufficient clinical data and these were excluded from the survival analysis. Children were classified in two age groups (< 10 years vs. >10 years) to investigate the characteristics of macrophages and DCs in younger vs older children (17) (18) (19) (20) (21) . This study was approved by the INCA Ethics Committee.
Histology
Diagnosis of cHL was established by morphologic criteria according to the WHO classification (22) . All cases were independently reviewed by two pathologists (MHMB and GN) as previously described (2) .
Tissue Microarray Design and Immunohistochemistry
Construction of tissue microarray (TMA) blocks has been described previously (2) . From each case, two 1-mm-diameter cores, selected from two different tumor areas rich in neoplastic cells, were included. TMA blocks were sectioned at a thickness of 3 μm.
Antigen retrieval was performed by heat treatment in a pressure-cooker for 1 minute.
Buffers used for antigen retrieval and primary antibodies are listed in the Supplemental Material (Table S1 ). Briefly, the antibodies used were CD14 (clone 7, Novocastra), CD68
(clone PGM1, Dako), CD163 (clone 10D6, Novocastra), CD83 (clone 1H4b, Novocastra) and CD207 (LANGERIN) (clone 12D6, Abcam). After incubation with primary antibody (30 minutes), immunodetection was performed using ZytoChem Plus HRP polymer kit (Zytomed Systems, Berlin, Germany) (Supplemental Material, Table S1 ), employing diaminobenzidine (DAB) chromogen as substrate. Sections were counterstained with hematoxylin. External and internal controls included in the TMA were taken into consideration to interpret staining results.
EBV Detection
Latent EBV infection was determined in all cases by in situ hybridization (ISH) with fluorescein-conjugated probes for EBV-encoded RNAs (EBER-ISH) and by IHC against latent membrane protein 1 (LMP1) as described (23) .
Computer Assisted Microscopical Analysis
For cell subset quantitative evaluation, each core was photographed using AxioCam MRc camera (Zeiss, Germany) at a 200x magnification. The numbers of labeled macrophages and DC were determined per 1mm 2 using the image analysis software HISTO (Biomas, Elangen, Germany).
Thresholds
Research. For each cell subset, the 25 th and 50 th percentiles were used to categorize the intensity of the cell infiltration. Cases displaying no labeled cell in both cores were considered not evaluable for technical reasons.
Statistical Analysis
Pearson's chi-square and Fisher's exact test were used to test association between dichotomous variables. Mann-Whitney test was used to compare medians, while Spearman´s rank correlation was used to test association between continuous variables.
First-order partial correlations were used to correlate two or more variables while keeping constant one or more additional variables and were computed as rank correlations (continuous variables) or point biserial rank correlations (categorical vs. continuous variables). Differences were considered significant at p< 0.05 in 2-tailed tests. Hierarchical cluster analysis using average linkage and binary simple matching measure allowed to explore the structure of association among variables of the tumor microenvironment and EBV-status. Primary treatment was defined as a failure if the lymphoma had progressed at any time after the initiation of therapy; treatment success was defined as the absence of progression or relapse. Progression-free survival (PFS) was the interval (in months) from diagnosis to progression at any time, relapse from complete response, or initiation of new, previously unplanned treatment or to the last follow-up in the patients with treatment success. Overall survival (OS) refers to the interval (in months) from the diagnosis to death or last follow-up. Survival distributions were estimated by the Kaplan-Meier method and differences were compared using log-rank test. Multivariate Cox proportional hazard regression method was used to determine the independent prognostic value of statistically significant variables in univariate analyses. Data were analyzed using Statistical Package for the Social Sciences 13.0 (SPSS). Clinical-pathological data of this pediatric group have been described previously (2) . In brief, the age at diagnosis ranged from 3 to 18 years (median 14 years) and 27% of children were <10 years. The majority of patients had stage I/II disease (59/95, 62.1%) and favorable clinical presentation (50/95, 52.6%). Extranodal disease was observed in 11 children (11/95, 11.6%). NS was the predominant subtype (69/100, 69%), followed by mixed cellularity (MC) (23/100, 23%). Granulomas were observed in 37% of cases (37/100 cases) (2). As described previously, EBV-positive HRS cells were detected in 44.8% of cases and no association with age-groups was observed (3) . A detailed description of EBV-association in relation to histological features has been published previously (2-3).
RESULTS
Research
Distribution of lymphocyte subsets in the tumor microenvironment in relation to age group, histology, EBV-status and their prognostic impact has been reported previously (2-3) and are summarized in table S3. The main clinical and histological characteristics of the patients are described in the Supplemental Material (Table S2) .
Macrophages and Dendritic Cells in Pediatric cHL
CD14+ monocyte/precursor cells, as well as CD163+ macrophages, CD83+
and CD207+ dendritic cells were distributed uniformly in the tumor microenvironment, without specific distribution pattern (Figure 1 ). CD68+ cells also showed uniform distribution in the majority of cases, but in 5 cases a rosette-like arrangement around HRS cells was observed.
The results of the quantitative analysis of CD68+, CD163+, CD14+, CD207+ and CD83+ cells are summarized in Table 1 . In general, the number of CD68+ cells was higher than that of CD163+ cells and of CD14+ cells. As expected, a strong correlation between CD68+ and CD163+ cells was observed (p<0.001), as well as between CD68+ and CD14+ cells (p<0.001). The numbers of CD83+ cells and CD14+ cells were similar. By contrast, LANGERIN+ cells were infrequently detected in the tumor microenvironment (Supplemental Material, Figure S1 ). No significant bivariate correlation was observed between CD83+, CD207+ and CD14+ cells. .
TAM are Associated with Clinical and Histological Features
The young age group (<10 years) was characterized by a higher number of 
TAM and Dendritic Cells are Associated with Lymphocyte Subsets in Tumor Microenvironment
Research.
on April The analysis of lymphocyte subset distribution in this pediatric cHL series has been published previously, and all data regarding the quantitative assessment of lymphocytes have been taken from those studies (2-3) (Supplemental Material, Table S3 ).
Numbers of macrophages and DCs were lower than the total number of CD3+ T cells. However, the number of CD68+ cells was higher than that of CD20+ B cells and the number of CD163+ cells was similar to that of CD8+ cells (Supplemental Material, Figure   S1 ).
As previously shown, the size of these lymphocyte subpopulations differed according to age, with a more cytotoxic composition observed in the <10 years group compared to a more suppressive profile in children older than 10 years. (2) (Supplemental Material, Table S3 ). To investigate if macrophages and DCs are associated with lymphocyte subpopulations a partial rank correlation analysis was carried out, controlled by age
The details of this analysis are provided in the supplemental material (Table   S4 ). In general, the numbers of CD14+ cells showed a direct correlation with the numbers of TBET+ (P< 0.0005), CD8+ (P= 0.019), TIA1+ (P= 0.024) and Granzyme B+ (P= 0.009) cells.
The numbers of CD68+ cells were directly correlated with the numbers of FOXP3+ (P< 0.0005), TIA1+ (P= 0.001) and Granzyme B+ (P = 0.001) cells (Supplemental Material, Table S4 ).
Numbers of CD163+ cells were directly correlated with those of TBET+ (P= 0.04), CD8+ (P= 0.025), TIA1+ (P= 0.001) and Granzyme B+ (P< 0.0005) cells (Supplemental Material, Table S4 ). 
EBV-Status of HRS Cells is Associated with the Number of TAM and Dendritic Cells in Pediatric cHL
Since EBV has been shown to modulate the tumor microenvironment composition in adult and childhood cHL (2, 24) , a preliminary data classification strategy using hierarchical cluster analysis was performed to identify underlying patterns of tumor microenvironment cell subsets according to EBV status (Figure 2 
On the other hand, a positive correlation was observed between CD68+ and FOXP3+ cell numbers only in EBV-negative cases, indicating that this is the source of the overall association observed between these two subpopulations in the microenvironment (see above). These analyses in EBV-negative cases also disclosed a relationship of CD163+ cells with both TBET+ cells and TIA1+ cells (Table 2) .
TAM and Dendritic Cells are Associated with Outcome
The OS at 60 months was 89.4%; stage and type of clinical presentation did not have impact on the OS (2) . No association was observed between single macrophage or DC populations and OS. A worse 5-year OS rate was observed in cases with CD163/CD8 ratio >2 (64.7% vs. 91.4% for ratio <2, P= 0.009, Log-rank test) and with CD83/CD20 ratio >2 (50% vs. 89.7% for ratio <2, P= 0.001, Log-rank test) (Figure 3) . The other ratios between macrophages, DCs and lymphocyte populations were not associated with survival. In the multivariate Cox regression, CD83/CD20 ratio >2 maintained statistical significance (P= 0.008; HR 7.3; 95%CI 1.6 to 31.5), while CD163/CD8 ratio showed a borderline significance (P= 0.06; HR 3.3; 95%CI 0.9 to 11.6).
PFS at 60 months was 78.6% (2) 
EBV Infection of HRS Cells May Influence the Prognostic Significance of CD163+ Cells in the Tumor Microenvironment
Given that EBV appears to be able to modulate the tumor microenvironment composition and local EBV-specific immunity (2, (24) (25) , the impact of the numbers of CD14+, CD68+, CD163+, CD207+ and CD83+ cells on PFS was investigated, according to EBV-status. In the EBV-negative group, a worse PFS rate was observed for cases with high numbers of CD163+ cells (>50 th percentile) (44.4%, P= 0.008, Log-rank), while no influence of a high number of CD163+ macrophages was observed in the EBV-positive group, although this was the group which generally exhibited higher numbers of CD163+ macrophages. The other cell populations showed no influence on PFS when cases were stratified by EBV-status.
Concerning the combined effect of Granzyme B+ and CD163+ cells, again, the impact on PFS was observed only in the EBV-negative group, with the worst PFS rate The effects of microenvironment variable on 5-year OS rate were also affected by EBV status. CD163/CD8 ratio >2 and CD83/CD20 >2 were associated with worse prognosis only in EBV-negative cases (50%, P= 0.005 and 40%, P= 0.002, respectively. Log-rank) (Figure 3) . described in non-small cell lung tumor (29) and in cutaneous squamous cell carcinoma (30) .
DISCUSSION
Moreover, it is of note that in our pediatric series, therapy response was not negatively affected by the presence of TAM in EBV+ cases, despite the high number of these cell subset that characterized the EBV+ cases. This reinforces the idea that, at least in the EBV+ cases, most TAMs are not of the M2 pro-tumoral subset and that CD163 probably is not a definitive marker of M2 polarization of macrophages.
In addition, we found a correlation between the numbers of CD68+ macrophages and Tregs in the EBV-negative cases, which again points to differences in the macrophage differentiation in the EBV+ and EBV-groups.
TAM are potentially one of the most powerful independent markers for clinical prediction in cHL and represent possible therapeutic targets (4-5, 27, 31-32). However, a number of technical issues, such as a consensus about the best quantification strategies, as well as marker selection, including monoclonal antibodies and molecular markers, are still matters of debate (27) .
We did not observe an independent prognostic impact of CD68+ cells on OS, contrary to what has been reported for adult cHL (5) . We used the macrophage-specific PG-M1 clone, contrary to many studies of adult cHL which employed CD68 KP1 clone to identify macrophages (4) (5) 33) . As KP1 is known to cross-react with different cell populations, including large lymphocytes (34-35), it is possible other cell populations stained with the KP1 antibody contribute to the adverse prognostic effect observed in previous studies. The absence of impact on the OS was also observed for CD163+ cells. It remains unclear in our specific pediatric population, if the absence of impact of macrophages and DC subpopulations (when analyzed separately) on OS was due to the success of rescue therapy or secondary to any other factor. Nevertheless, we observed that CD163/CD8 ratio >2 and CD83/CD20 >2 were associated with worse OS, suggesting CD83 (clone 1H4b) has been shown to be a specific marker for mature and activated DCs and does not cross-react with macrophages (26, 36) . In support of this notion, in our study, numbers of CD83+ cells did not correlate with those of CD14+, CD68+ or CD163+ cells. Also, we observed that the numbers of CD83+ DCs were directly correlated with the numbers of FOXP3+ cells. As it has been described that pDCs are able to induce primary Treg cell differentiation (13) (14) , it is possible that part of these CD83+ cells were pDC and that they were engaged in Treg cell differentiation. However, the CD83 antibody is not able to differentiate myeloid DCs from pDCs (36) (37) and this issue requires further investigation. The prognostic impact of tumor-associated DCs on survival of cancer patients is controversial; in some studies a higher number of these cells was associated with a better outcome (38) (39) , while in others, the specific pDC subset has been associated with worse outcome (40) (41) (42) . Here, an excess of DCs was associated with worse OS, when analyzed in relation to B cells (CD83/CD20 ratio >2). This highlights We are aware that the number of cases in this study imposes limitation in relation to the analysis of prognostic impact and prospective studies are mandatory to confirm our results. However, our series of sequential cases with similar distribution in relation to EBV-status is appropriate for the immunological evaluation performed here.
In summary, our results suggest that in pediatric cHL the macrophage composition is numerically and functionally distinct from adults, and that the functional 
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